One Dose of HPV Vaccine May Be Sufficient in Certain Situations
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings.
Cervical Cancer
Cancer Risks Examined in Rheumatoid Arthritis Patients
Increased incidences found for lymphoma, lung cancer (in male patients), and cervical cancer.
Targeted Interventions Raise HPV Vaccine Acceptance in Women
Educational videos produced the highest rate of acceptability and knowledge.
Experts Recommend Cytologic Test Every 3 Years, High-Risk HPV Test Every 5 Years
A new study challenges the recommended use of cotesting for cervical cancer screening.
Higher Surgical Volume May Improve Outcomes in Cervical Cancer
Findings show radical hysterectomy at high-volume centers tied to better survival in early cervical cancer.
Some Cervical Cancer Screening Strategies More Cost-Effective
Most lifetime QALYs seen with cytologic testing every three years, repeated for ASC-US.
Brachytherapy Boost Ups Survival in Locally Advanced Cervical Cancer
Findings observed regardless of treatment duration; disparities for brachytherapy use seen in vulnerable populations.
ePRO Tool Improves Symptom Management in an Outpatient Gynecologic Cancer Clinic
Investigators sought to determine if electronic patient-reported outcome tools with the PROMIS network improved identifying patients with severe symptoms and increased referrals to ancillary support services.
Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women
Survey sought to assess the relative implicit biases of gynecologic healthcare providers regarding women with diagnoses of cervical vs ovarian cancer.
Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
A comparison study of 2 approaches to radical hysterectomy found that disease-free and overall survival are worse with minimally invasive procedure than with abdominal open procedure, contradicting previous study findings.
Next post in Gynecologic Cancer
